Free Trial
CVE:DB

Decibel Cannabis (DB) Stock Price, News & Analysis

Decibel Cannabis logo
C$0.08 +0.01 (+6.25%)
As of 07/11/2025 03:59 PM Eastern

About Decibel Cannabis Stock (CVE:DB)

Key Stats

Today's Range
C$0.08
C$0.09
50-Day Range
C$0.07
C$0.09
52-Week Range
C$0.04
C$0.09
Volume
192,111 shs
Average Volume
265,950 shs
Market Capitalization
C$34.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$0.30
Consensus Rating
N/A

Company Overview

Decibel Cannabis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

DB MarketRank™: 

Decibel Cannabis scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Decibel Cannabis is -8.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Decibel Cannabis is -8.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Decibel Cannabis has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for DB.
  • Dividend Yield

    Decibel Cannabis does not currently pay a dividend.

  • Dividend Growth

    Decibel Cannabis does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for DB.
  • Search Interest

    6 people have searched for DB on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Decibel Cannabis insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$82,275.00 in company stock and sold C$0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.07% of the stock of Decibel Cannabis is held by insiders.

  • Percentage Held by Institutions

    Only 0.79% of the stock of Decibel Cannabis is held by institutions.

  • Read more about Decibel Cannabis' insider trading history.
Receive DB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Decibel Cannabis and its competitors with MarketBeat's FREE daily newsletter.

DB Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Decibel Cannabis Reports Q3 Revenue Growth and Strong Margins
See More Headlines

DB Stock Analysis - Frequently Asked Questions

Decibel Cannabis' stock was trading at C$0.07 at the start of the year. Since then, DB stock has increased by 21.4% and is now trading at C$0.09.

Shares of DB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Decibel Cannabis investors own include AutoZone (AZO), Intel (INTC), CSLM Acquisition (SPWR), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM) and Bank of America (BAC).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Banking
Current Symbol
CVE:DB
CIK
N/A
Fax
N/A
Employees
83,000
Year Founded
N/A

Price Target and Rating

High Price Target
C$0.40
Low Price Target
C$0.20
Potential Upside/Downside
+252.9%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Trailing Twelve Months)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.50
P/E Growth
N/A
Net Income
-C$1.03 million
Net Margins
-3.78%
Pretax Margin
N/A
Return on Equity
-1.05%
Return on Assets
3.04%

Debt

Debt-to-Equity Ratio
107.39
Current Ratio
1.27
Quick Ratio
N/A

Sales & Book Value

Annual Sales
C$105.60 million
Price / Sales
0.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
C$0.10 per share
Price / Book
0.85

Miscellaneous

Outstanding Shares
409,040,000
Free Float
N/A
Market Cap
C$34.77 million
Optionable
N/A
Beta
1.03
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (CVE:DB) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners